Table 2: Effects of paracetamol injury and A. blazei pretreatment on plasma enzyme activities, albumin levels, and bilirubin concentration. For experimental details see Section 2.

ParametersGroups
I, controlII, A. blazei pretreatmentIII, paracetamol injuryIV, A. blazei pretreatment + paracetamol injury

Aspartate aminotransferase (AST, U/L)74.6 ± 9.3 ( )71.6 ± 4.0 ( )512.9 ± 62.7 ( )a,b,c246.6 ± 65.2 ( )d,e
Alanine aminotransferase (ALT, U/L)65.3 ± 4.2 ( )63.7 ± 2.6 ( )447.0 ± 52.0 ( )a,b,c280.2 ± 64.0 ( )d,e
Lactate dehydrogenase (LDH, U/L)248.9 ± 12.5 ( )227.7 ± 38.1 ( )531.0 ± 36.8 ( )a,b,c304.4 ± 24.7 ( )
Alkaline phosphatase
(ALP, U/L)
74.6 ± 14.8 ( )72.6 ± 3.6 ( )174.1 ± 16.2 ( )a,b,c123.3 ± 5.6 ( )d,e
Albumin (g/L)2.37 ± 0.09 ( )2.21 ± 0.14 ( )2.48 ± 0.20 ( )2.22 ± 0.10 ( )
Total bilirubin (mg/dL)0.53 ± 0.01 ( )0.35 ± 0.01 ( )0.80 ± 0.01 ( )b0.64 ± 0.11 ( )e
Conjugated bilirubin (mg/dL)0.07 ± 0.01 ( )0.07 ± 0.01 ( )0.24 ± 0.01 ( )a,b,c0.17 ± 0.01 ( )d,e

Significant differences ( ), according to one-way ANOVA followed by Student-Newman-Keuls post-hoc testing, are identified by the superscript letters as follows: aIII versus I; bIII versus II; cIII versus IV; dIV versus I; eIV versus II.